Financial reports
10-K
2023 FY
Annual report
27 Mar 24
20-F
2022 FY
Annual report (foreign)
28 Mar 23
20-F
2021 FY
Annual report (foreign)
31 Mar 22
20-F
2020 FY
Annual report (foreign)
31 Mar 21
20-F
2019 FY
Annual report (foreign)
15 Jun 20
20-F/A
2018 FY
Annual report (foreign) (amended)
29 May 19
20-F
2018 FY
Annual report (foreign)
29 Apr 19
Current reports
8-K
Entry into a Material Definitive Agreement
15 Apr 24
8-K
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
27 Mar 24
8-K
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
8 Jan 24
6-K
Current report (foreign)
18 Dec 23
6-K
Current report (foreign)
29 Nov 23
6-K
Current report (foreign)
16 Nov 23
6-K
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
23 Oct 23
6-K
Current report (foreign)
17 Oct 23
6-K
Current report (foreign)
20 Sep 23
6-K
Current report (foreign)
7 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
23 Jan 24
8-A12B/A
Registration of securities on exchange (amended)
18 Dec 23
S-8
Registration of securities for employees
24 Jan 23
8-A12B/A
Registration of securities on exchange (amended)
17 May 22
S-8
Registration of securities for employees
13 Jan 22
F-3/A
Shelf registration (foreign) (amended)
27 Sep 21
F-3/A
Shelf registration (foreign) (amended)
7 Sep 21
F-6EF
Automatic registration for ADRs (foreign)
13 Aug 21
F-3
Shelf registration (foreign)
5 Aug 21
424B5
Prospectus supplement for primary offering
10 Feb 21
Proxies
No filings
Other
UPLOAD
Letter from SEC
24 Aug 22
CORRESP
Correspondence with SEC
19 Aug 22
UPLOAD
Letter from SEC
8 Aug 22
CT ORDER
Confidential treatment order
10 Jun 22
EFFECT
Notice of effectiveness
1 Oct 21
CORRESP
Correspondence with SEC
29 Sep 21
UPLOAD
Letter from SEC
21 Sep 21
CORRESP
Correspondence with SEC
7 Sep 21
UPLOAD
Letter from SEC
20 Aug 21
EFFECT
Notice of effectiveness
22 Oct 20
Ownership
SC 13D/A
Rubric Capital Management LP
16 Apr 24
SC 13G/A
ORBIMED ADVISORS LLC
14 Feb 24
SC 13G/A
Rock Springs Capital Management LP
14 Feb 24
SC 13G/A
Rock Springs Capital Management LP
14 Feb 24
SC 13G
MANGROVE PARTNERS IM, LLC
14 Feb 24
SC 13G/A
SUVRETTA CAPITAL MANAGEMENT, LLC
13 Feb 24
4
Anders Ekblom
9 Feb 24
4
Pierre Jacquet
9 Feb 24
4
Marc J Yoskowitz
9 Feb 24
4
DEEPIKA PAKIANATHAN
9 Feb 24